Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Human Embryonic Stem Cell Market to Grow at a CAGR of 10% in the Forecast Period of 2022-2027, Aided by Robust Research and Development Activities

According to a new report by EMR titled, ‘Global Human Embryonic Stem Cell Market Report and Forecast 2022-2027’, the global human embryonic stem cell industry reached a value of about USD 0.7 billion in 2020. The industry is further expected to grow at a CAGR of about 10% in the forecast period of 2022-2027.

The advancements in technologies and growing research and development investments, and research initiatives are expected to generate new opportunities for the human embryonic stem cell market. Controlled differentiation that can be achieved in tissue committed cells through the co-culturing with basic fibroblast growth factor is expected to induce growth. North America dominates the human embryonic stem cell market due to the presence of a major number of players and the high incidence of diseases such as diabetes, heart disease, renal failure, and osteoporosis within the region. The rising prevalence of cardiac and malignant diseases around the world is expected to have a significant impact on demand, accelerating the market's growth. To boost the pace of stem cell research, the government is providing funding opportunities to researchers.

Rising investment in the industry is likely to aid the growth of the industry further in the coming years. The growth can be attributed to the increasing public-private funding and research grants for developing safe and effective stem cell therapy products and the growing number of clinical trials. For example, in July 2021, Astellas Pharma Inc. (OTCMKTS: ALPMY) announced a worldwide strategic collaboration and license agreement for the research, development, and commercialisation of novel cell therapy programs for diseases caused by mitochondrial dysfunction. This will augment the growth of the market as the availability of facilities will increase as a result of increased investment in the R&D sector of the market.

Market Analysis by Applications and Regions:

  • The leading applications segments in the industry are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing.
  • The regional markets for human embryonic stem cell market include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • Advancements in stem culturing and derivation, along with rapid progress in laboratory technologies, are expected to play a key role in the overall growth of the market.
  • Rapid advancements also include the establishment of various disease models and the evaluation of therapeutic potential in treating incurable diseases, which is likely to bolster the industry growth.
  • The demand for newer and better therapies to treat autoimmune, neurological, and cardiovascular diseases has resulted in an increase in research activities and funding for cell-based research.
  • Rapidly increasing population is also one of the factors that are expected to boost the growth of the market.

Key Offerings of the report:

  • The EMR report gives an overview of the global human embryonic stem cell market for the periods (2017-2021) and (2022-2027).
  • The report also offers the historical (2017-2021) and forecasted (2022-2027) markets applications and major regions of the human embryonic stem cell market.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER